Senile myoclonic epilepsy: Delineation of a common condition associated with Alzheimer's disease in Down syndrome

Seizure

Volumn 19, Issue 7, 2010, Pages 383-389

  De Simone, Roberto ^a,b   Puig, Xavier Salas ^c   Gélisse, Philippe ^d   Crespel, Arielle ^d   Genton, Pierre ^a  

^a CENTRE SAINT PAUL   (France)

^b S EUGENIO HOSPITAL   (Italy)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d GUI DE CHAULIAC HOSPITAL   (France)

Author keywords

Down; Epilepsy; Myoclonic

Indexed keywords

ETIRACETAM; LAMOTRIGINE; PHENOBARBITAL; PIRACETAM; TOPIRAMATE; VALPROIC ACID;

ALZHEIMER DISEASE; ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE MARKER; DOWN SYNDROME; HUMAN; LIFE EXPECTANCY; MIDDLE AGED; MORBIDITY; MYOCLONUS EPILEPSY; PRIORITY JOURNAL; PROGNOSIS;

EID: 77955981514     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2010.04.008     Document Type: Article

References (51)

1. Veall RM. Theprevalence of epilepsy among mongols related to age. J Ment Def Res 1974;18:99-106.
2. Stafstrom CE, Gilmore HE, Ehrenberg GL. Seizures in persons with Down syndrome: cause and prognosis. Ann Neurol 1988;24:308-9.
3. Stafstrom CE, Patxot OF, Gilmore HE, Wisniewski KE. Seizures in children with Down syndrome: etiology, characteristics and outcome. Dev Med Child Neurol 1991;33:191-200.
4. Stafstrom CE. Epilepsy in Down syndrome: clinical aspects and possible mechanisms. Am J Ment Ret 1993;98(Suppl.):12-26.
5. Pueschel SM, Louis S, Mc Knight P. Seizure disorders in Down syndrome. Arch Neurol 1991;3(March (48)):318-20.
6. Bittles AH, Bower C, Hussain R, Glasson EJ. The four ages of Down syndrome. Eur J Public Health 2007;17(April (2)):221-5.
7. Schweber MS. Alzheimer's disease and Down syndrome. Prog Clin Biol Res 1989;317:247-67.
8. Margallo-Lana ML, Moore PB, Kay DW, Perry RH, Reid BE, Berney TP, et al. Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology. J Intellect Disabil Res 2007;51(June (Pt. 6)):463-77.
9. Lai F, Williams RS. A prospective study of Alzheimer disease in Down syndrome. Arch Neurol 1989;46:849-53.
10. Evenhuis HM. The natural history of dementia in Down's syndrome. Arch Neurol 1990;47:263-7.
11. Genton P, Paglia G. Epilepsie myoclonique sénile? Myoclonies d'apparition tardive dans le syndrome de Down. Epilepsies 1994;1:5-11.
12. Li LM, O'Donoghue MF, Sander JW. Myoclonic epilepsy of late onset in trisomy 21. Arq Neuropsiquiatr 1995;53(December (4)):792-4. [Review].
13. Möller JC, Hamer HM, Oertel WH, Rosenow F. Late-onset myoclonic epilepsy in Down's syndrome (LOMEDS). Seizure 2001;10(June (4)):303-5.
14. Möller JC, Hamer HM, Oertel WH, Rosenow F. Late-onset myoclonic epilepsy in Down's syndrome (LOMEDS). Seizure 2002;11(April (Suppl. A)):303-5.
15. De Simone R, Daquin G, Genton P. Senile myoclonic epilepsy in Down syndrome: a video and EEG presentation of two cases. Epileptic Disord 2006;8:223-7.
16. Crespel A, Gonzalez V, Coubes P, Gelisse P. Senile myoclonic epilepsy of Genton: two cases in Down syndrome with dementia and late-onset epilepsy. Epilepsy Res 2007;77:165-8.
17. Pedersen B. Epilepsy of late onset in Down's syndrome: a new epileptic syndrome. Epilepsia 1990;31(5):613.
18. Van Allen MI, Fung J, Jurenka SB. Heath care concerns and guidelines for adults with Down syndrome. Am J Med Genet 1999;89(2):100-10.
19. Tatsuno M, Hayashi M, Iwamoto H, Suzuki Y, Kuroki Y. Epilepsy in childhood Down syndrome. Brain Dev 1984;6(1):37-44.
20. Kwoiong KL, Wong V. Neurodevelopmental profile of Down syndrome in Chinese people. J Paediatr Child Health 1996;32(2):153-7.
21. McVicker RW, Shanks OEP, McClelland RJ. Prevalence and associated features of epilepsy in adults with Down's syndrome. B J Psychiatry 1994;164:528-32.
22. Guerrini R, Genton P, Bureau M, Dravet C, Roger J. Reflex seizures are frequent in patient with Down syndrome and epilepsy. Epilepsia 1990;31:406-17.
23. Pueschel SM, Louis S. Reflex seizures in Down syndrome. Child's Nerv Syst 1993;9(February (1)):23-4.
24. Guerrini R, Battaglia A, Stagi P, Bureau M, Genton P, Camara-Silva A, et al. Caratteristiche elettrocliniche dell'epilessia nella sindrome di Down. Boll Lega It Epil 1989;66/67:317-9.
25. Kemper TL. Neuropathology of Down syndrome. In: Nadel L, editor. The psychopathology of Down syndrome. Cambridge, MA: MIT Press; 1988. p. 269-89.
26. Wisniewski KE, Laure-Kamionowska M, Connell F, Wen GY. Neuronal density and synaptogenesis in the postnatal stage of brain maturation in Down syndrome. In: Epstein C, editor. The neurobiology of Down syndrome. New York, NY: Raven Press; 1986. p. 29-44.
27. Scott BS, Petit TL, Becker LE, Edwards BAV. Abnormal electric membrane properties of Down's syndrome DRG neurons in cell culture. Brain Res 1982;2:257-70.
28. McCoy EE, Enns L. Current status of neurotransmitters abnormalities in Down syndrome. In: Epstein CJ, editor. The neurobiology of Down syndrome. 1986:73-87.
29. Florez J, del Arco C, Gozales A, Pascual J, Pazos A. Autoradiographic studies of neurotransmitter receptors in the brain of newborn infants with Down syndrome. Am J Med Gen Sup 1990;7:301-5.
30. Eubanks JH, Puranam RS, Kleckner NW, Bettler B, Heinemann SF, McNamara JO. The gene encoding the glutamate receptor subunit GluR5 is located on human chromosome 21q21.1-22.1 in the vicinity of the gene for familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 1993;90:178-82.
31. Thiel RJ, Fowkes SW. Down syndrome and epilepsy: a nutritional connection? Med Hypotheses 2004;62:35-44.
32. Werbach M. Epilepsy. Textbook of nutritional medicine. Tarzana, CA: Third Line Press; 1999. p. 363-75.
33. Johannsen P, Christensen JEJ, Goldstein H, Nielsen VK, Mai J. Epilepsy in Down syndrome-prevalence in three age groups. Seizure 1996;5(June (2)):121-5.
34. Hauser WA, Morris ML, Heston LL, Anderson VE. Seizures and myoclonus in patients with Alzheimer's disease. Neurology 1986;36:1226-30.
35. Wilkins DE, Hammett M, Berardelli A, Walshe T, Alvarez N. Physiological analysis of the myoclonus of Alzheimer's disease. Neurology 1984;34:898-903.
36. Bugiani O, Tagliavini F, Giaccone G. Preamyloid deposits, amyloid deposits, and senile plaques in Alzheimer's disease, Down syndrome, and aging. Ann NY Acad Sci 1991;640:122-8.
37. Wisniewsky H, Wiegel J, Popovitch E. Age associated development of diffuse and thioflavin 5-positive plaques in Down syndrome. Dev Br Dysf 1995;7:330-9.
38. Prasher VP, Krishnan VHR. Ageofonset and duration of dementia in people with Down syndrome. Integration of 98 reported cases in the literature. Int J Geriatr Psychiatry 1993;10:25-31.
39. Rumple B, Retallack R, Hilbich C, Simms G, Multhaup G, Martins R, et al. Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. NEJM 1989;320:1446-52.
40. Lockstone HE, Harris LW, Swatton JE, Wayland MT, Holland AJ, Bahn S. Gene expression profiling in the adult Down syndrome brain. Genomics 2007;90(De-cember (6)):647-60.
41. Lott IT, Head E, Doran E, Busciglio J. Beta-amyloid, oxidative stress and Down syndrome. Curr Alzheimer Res 2006;3(December (5)):521-8.
42. Cheon MS, Dierssen M, Kim SH, Lubec G. Protein expression of BACE1, BACE2 and APP in Down syndrome brains. Amino Acids 2007. [December 29; Epub ahead of print].
43. Ryoo SR, Jeong HK, Radnaabazar C, Yoo JJ, Cho HJ, Lee HW, et al. DYRK1A-mediated hyperphosphorylation of Tau. A functional link between Down syndrome and Alzheimer disease. J Biol Chem 2007;282(November (48)):34850-7.
44. Menéndez M. Down syndrome, Alzheimer's disease and seizures. Brain Dev 2005;27(June (4)):246-52.
45. Prasher VP, Sajith SG, Rees SD, Patel A, Tewari S, Schupf N, et al. Significant effect of APOE epsilon 4 genotype on the risk of dementia in Alzheimer's disease and mortality in persons with Down syndrome. Int J Geriatr Psychiatry 2008. [May 8; Epub ahead of print].
46. Schupf N. Genetic and host factors for dementia in Down's syndrome. Br J Psychiatry 2002;180:405-10.
47. Collacott RA, Cooper SA. Epilepsy in adults with Down syndrome. Br J Psychiatry 1994;165(July (1)):117.
48. Aylward EH, Burt DB, Thorpe LU, Lai F, Dalton A. Diagnosis of dementia in individuals with intellectual disability. J Intell Disabil Res 1997;41:152-64.
49. Thomas P, Genton P, Gelisse P, Wolf P. Epilepsie myoclonique juvénile. In: Les syndromes épileptiques de l'enfant et de l'adolescent. John Libbey Eurotext. p. 269-88.
50. Dolk H, Loane M, Garne E, De Walle H, Queisser-Luft A, De Vigan C, et al. Trends and geographic inequalities in the prevalence of Down syndrome in Europe, 1980-1999. Rev Epidemiol Sante Publique 2005; 53 (November (Spec No. 2)). 2S87-95.
51. de Vigan C, Khoshnood B, Cadio E, Vodovar V, Goffinet F. Prenatal diagnosis and prevalence of Down syndrome in the Parisian population, 2001-2005. Gynecol Obstet Fertil 2008;36(2):146-50.